Inari Medical, Inc.
NARI · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $2,407,029 | $2,918,170 | $2,733,520 | $3,741,962 |
| - Cash | $41,141 | $70,192 | $66,707 | $39,208 |
| + Debt | $32,724 | $33,149 | $31,492 | $32,047 |
| Enterprise Value | $2,398,612 | $2,881,127 | $2,698,305 | $3,734,801 |
| Revenue | $153,390 | $145,820 | $143,194 | $132,094 |
| % Growth | 5.2% | 1.8% | 8.4% | – |
| Gross Profit | $133,544 | $122,278 | $124,301 | $113,955 |
| % Margin | 87.1% | 83.9% | 86.8% | 86.3% |
| EBITDA | -$7,210 | -$16,608 | -$11,393 | -$947 |
| % Margin | -4.7% | -11.4% | -8% | -0.7% |
| Net Income | -$18,367 | -$31,348 | -$24,202 | -$4,667 |
| % Margin | -12% | -21.5% | -16.9% | -3.5% |
| EPS Diluted | -0.31 | -0.54 | -0.42 | -0.081 |
| % Growth | 42.6% | -28.6% | -418.5% | – |
| Operating Cash Flow | $2,712 | $11,513 | -$12,288 | $12,241 |
| Capital Expenditures | -$3,707 | -$4,580 | -$1,910 | -$2,400 |
| Free Cash Flow | -$995 | $6,933 | -$14,198 | $9,841 |